Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
547.09
+4.59 (0.85%)
At close: Nov 6, 2026, 4:00 PM EST
546.21
-0.88 (-0.16%)
After-hours: Nov 6, 2026, 7:59 PM EST
Vertex Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $575 → $620 | Buy | Reiterates | $575 → $620 | +13.33% | Nov 4, 2026 |
| Barclays | Barclays | Buy Maintains $617 → $626 | Buy | Maintains | $617 → $626 | +14.42% | Nov 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $641 | Buy | Reiterates | $641 | +17.17% | Nov 3, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $600 → $620 | Buy | Maintains | $600 → $620 | +13.33% | Nov 3, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $667 | Buy | Reiterates | $667 | +21.92% | Nov 3, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $550 → $575 | Buy | Maintains | $550 → $575 | +5.10% | Nov 3, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $595 → $619 | Buy | Maintains | $595 → $619 | +13.14% | Nov 3, 2026 |
| Scotiabank | Scotiabank | Buy Reiterates $660 | Buy | Reiterates | $660 | +20.64% | Nov 3, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.